Evotec SE EVO

EVO Company Overview

Evotec SE is a Germany-based biotechnology company focused on drug discovery, preclinical development, and manufacturing services for pharmaceutical, biotechnology, and academic partners. The company operates within the life sciences and biopharmaceutical industries, providing integrated research platforms that support the development of therapeutics across areas including neuroscience, oncology, metabolic diseases, infectious diseases, immunology, fibrosis, and rare diseases. Evotec’s business model combines fee-for-service research, long-term strategic partnerships, milestone payments, royalties, and shared intellectual property participation.

The company’s primary revenue drivers are its discovery and development collaborations, platform-based research services, and biologics manufacturing activities. Through its evolution from a technology-driven discovery company founded in 1993 in Hamburg, Evotec expanded into a broader drug development and biotechnology platform through acquisitions, alliances, and investments in precision medicine and biologics capabilities. Its strategic positioning is built around large-scale scientific infrastructure, data-driven drug discovery, induced pluripotent stem cell (iPSC) technologies, and long-term collaborations with major pharmaceutical companies.